News | PET-CT | August 15, 2019

United Imaging Announces First U.S. Clinical Installation of uExplorer Total-body PET/CT

uExplorer molecular imaging technology now in use at UC Davis Health

United Imaging Announces First U.S. Clinical Installation of uExplorer Total-body PET/CT

August 15, 2019 — United Imaging announced that its uExplorer total-body positron emission tomography/computed tomography (PET/CT) system is now in use.

United Imaging developed uExplorer in partnership with the Explorer Consortium led by Simon Cherry, Ph.D., and Ramsey Badawi, Ph.D., from the University of California Davis. UC Davis Health has now completed installation of the uEexplorer and is actively using the technology for patient scans.

Part of United Imaging's all-digital PET/CT portfolio, uExplorer accomplishes total-body imaging in a single bed position in as little as 20 to 30 seconds. It also allows for fast and continuous tracking of tracer distribution in blood, organs and tissues throughout the body. With these capabilities, the uExplorer opens new research opportunities that have not been possible with traditional PET/CT technology. More specifically, the system offers support for pharmacokinetic studies and radiation dose evaluation.

"We're very proud that UC Davis Health is the site of the first uExplorer installation in North America," said Badawi, chief of nuclear medicine at UC Davis. "The images we're seeing with uExplorer are unprecedented. We're capturing detail we have never seen before, and I am sure this is going to positively affect patient care."

Added Cherry, professor of biomedical engineering and radiology, "We can now capture the dynamic distribution of our tracers at incredibly high temporal resolution, opening up new opportunities for innovative research using this powerful technology platform."

The first clinical patient in the U.S. to be scanned using the uExplorer was Magdalena Gonzalez, 49, a mother of seven who was scanned for the purpose of better staging her lymphoma.

For more information: www.united-imaging.com

Related Content

RefleXion Highlights Novel Approach to Radiotherapy at ASTRO 2019

The RefleXion X1 Machine without the Gantry Cover. The patented technology incorporates PET imaging data, which enables tumors to continuously signal their location. Image courtesy of Reflexion Medical.

News | Radiation Therapy | September 12, 2019
Therapeutic oncology company RefleXion Medical announced it will showcase the RefleXion X1 Machine at the American...
ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
A 3-D printed tungsten pre-clinical X-ray system collimator. 3D printed, additive manufacturing for medical imaging.

A 3-D printed tungsten pre-clinical X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix. 

Feature | Medical 3-D Printing | September 04, 2019 | By Steve Jeffery
In ...
A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one hold out who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.

A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one holdout who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.

Feature | Nuclear Imaging | August 30, 2019 | Dave Fornell, Editor
In a surprising move, the National Institute for Radioelements (IRE) has applied for a new license to export highly e
University of Alabama at Birmingham Leading Production of Theranostic Radioisotope

Image courtesy of the University of Alabama at Birmingham

News | Radiopharmaceuticals and Tracers | August 29, 2019
The University of Alabama at Birmingham, in conjunction with researchers at the University of Wisconsin and Argonne...
ASRT Supports Radiopharmaceutical Reimbursement Bill
News | Radiopharmaceuticals and Tracers | August 02, 2019
The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) 3772, a measure...
International Multidisciplinary Group Publishes Recommendations for Personalized HCC Treatment With Y90 TheraSphere
News | Interventional Radiology | July 31, 2019
New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have...
NorthStar Medical Radioisotopes Awarded $30 Million by U.S. Department of Energy
News | Radiopharmaceuticals and Tracers | July 26, 2019
NorthStar Medical Radioisotopes LLC has been awarded $15 million in a cooperative agreement with the U.S. Department of...
NorthStar Medical Radioisotopes Completes Construction on Beloit, Wis. Molybdenum-99 Processing Facility
News | Radiopharmaceuticals and Tracers | July 16, 2019
NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-...
Bracco Imaging Acquires Blue Earth Diagnostics
News | Radiopharmaceuticals and Tracers | July 01, 2019
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company...